Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GLD vs MRNA✓SelectedUSD · MRNAGLD vs MRNA performance historyLatest closeAs of-3.67%11/20
Stock and ETF performance explorer

GLD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.3%
MRNA return
-27.3%
Excess return
+118.6%
Maximum drawdown
-34.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.7%-2.2%-1.5%-3.6%
7D-9.2%-12.7%+3.5%-8.8%
30D-14.8%-20.7%+5.9%-14.3%
3M-22.2%+46.3%-68.5%-23.2%
6M-22.6%+305.2%-327.9%-27.3%
YTD-18.5%+561.2%-579.8%-24.2%
1Y-13.9%+772.1%-786.0%-20.3%
3Y+76.1%+147.0%-70.9%+64.9%
All+91.3%-27.3%+118.6%+82.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling